CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy 10% owner bought 18,442 shares at an average $1.79 ($33,019)
- 4 Open-market buy 10% owner bought 87,801 shares at an average $1.81 ($158,601)
- 4 Open-market buy 10% owner bought 4,256 shares at $1.88 ($8,001)
- 4 Open-market buy 10% owner bought 71,065 shares at an average $1.92 ($136,178)
- 4 Open-market buy 10% owner bought 14,632 shares at an average $2.03 ($29,683)
- 4 Open-market buy 10% owner bought 60,490 shares at an average $2.05 ($123,819)
- 4 Open-market buy 10% owner bought 7,849 shares at $2.09 ($16,404)
- 4/A Open-market buy 10% owner bought 15,089 shares at $2.10 ($31,687)
- 4 Open-market buy 10% owner bought 15,089 shares at $2.10 ($31,687)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy 10% owner bought 15,229 shares at an average $2.09 ($31,896)
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at $2.14 ($214,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 30 · 596 filings